BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 27, 2001
View Archived Issues
BAIPs with broad-spectrum anti-HIV activity available for licensing from NIH
Read More
Combination of PDE4 and PDE3 inhibitors for Th1-mediated autoimmune diseases
Read More
Johnson & Johnson/Alza complete merger
Read More
EntreMed and Aventis establish collaborative agreement for phase II prostate cancer trial
Read More
Pivotal data reported for Xanelim in psoriasis
Read More
Modulation of mitochondrial metabolism as a novel treatment strategy for type 2 diabetes
Read More
Potent and selective glucagon receptor antagonist as potential new therapy for type 2 diabetes
Read More
Genelabs' NDA for Aslera deemed unapprovable by FDA
Read More
Maxia designs molecule with antidiabetic and antidyslipidemic effects
Read More
Vion's sulfonylhydrazine prodrug enters phase I evaluation
Read More
TBC-1269 enters clinical evaluation as inhaled therapy for asthma
Read More
Cellegy files NDA for Anogesic; completes enrollment in second phase III trial
Read More
Novuspharma's IND for BBR-2778 accepted by FDA
Read More
Selective activation of pancreatic beta-cell K(ATP) channel achieved by diazoxide analogue
Read More
Symbollon announces plans for phase III IoGen trials; completes name change
Read More
Health Canada approves Levulan Kerastick
Read More
ADA news: Telik designs orally active insulin receptor tyrosine kinase activator
Read More
Versicor initiates phase II study of novel antifungal agent for invasive candidiasis/candidemia
Read More
Positive phase I results reported for Active Biotech's TTS
Read More
Novel class of therapeutics for type 2 diabetes: small-molecule glucokinase activators
Read More
Vasogen completes patient enrollment in congestive heart failure trial
Read More
Inhibitors of beta-amyloid peptide production or release discovered at Lilly
Read More
New Aventis compounds useful as anticoagulants for thrombotic disorders
Read More
Japanese pharmaceutical company presents new hypoglycemic agents
Read More
Stable GLP-1 analogue with enhanced in vivo efficacy: BIM-51077
Read More
Antiviral agents active against HSV-1 patented by Toagosei
Read More
Sankyo designs dihydroquinoline ileal bile acid transport inhibitors
Read More